These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 36124494)
21. BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: A structured summary of a study protocol for a randomised controlled trial. Junqueira-Kipnis AP; Dos Anjos LRB; Barbosa LCS; da Costa AC; Borges KCM; Cardoso ADRO; Ribeiro KM; Rosa SBA; Souza CC; das Neves RC; Saraiva G; da Silva SM; Silveira EA; Rabahi MF; Conte MB; Kipnis A Trials; 2020 Oct; 21(1):881. PubMed ID: 33106170 [TBL] [Abstract][Full Text] [Related]
22. Protection against tuberculosis by Bacillus Calmette-Guérin (BCG) vaccination: A historical perspective. Setiabudiawan TP; Reurink RK; Hill PC; Netea MG; van Crevel R; Koeken VACM Med; 2022 Jan; 3(1):6-24. PubMed ID: 35590145 [TBL] [Abstract][Full Text] [Related]
23. The role of BCG vaccine in the prevention and control of tuberculosis in the United States. A joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices. MMWR Recomm Rep; 1996 Apr; 45(RR-4):1-18. PubMed ID: 8602127 [TBL] [Abstract][Full Text] [Related]
24. Health economic evaluation of current vaccination strategies and new vaccines against tuberculosis: a systematic review. Machlaurin A; Pol SV; Setiawan D; van der Werf TS; Postma MJ Expert Rev Vaccines; 2019 Sep; 18(9):897-911. PubMed ID: 31369299 [No Abstract] [Full Text] [Related]
25. The potential impact of vaccination on tuberculosis burden in India: A modelling analysis. Arinaminpathy N; Rade K; Kumar R; Joshi RP; Rao R Indian J Med Res; 2023; 157(2&3):119-126. PubMed ID: 37202930 [TBL] [Abstract][Full Text] [Related]
26. [Where do we stand with BCG vaccination programme in Japan?]. Mori T Kekkaku; 2001 Apr; 76(4):385-97. PubMed ID: 11398330 [TBL] [Abstract][Full Text] [Related]
27. Bacillus Calmette-Guérin (BCG) Revaccination and Protection Against Tuberculosis: A Systematic Review. Lawrence A Cureus; 2024 Mar; 16(3):e56643. PubMed ID: 38646352 [TBL] [Abstract][Full Text] [Related]
28. The role of antibodies in Bacille Calmette Guérin-mediated immune responses and protection against tuberculosis in humans: A systematic review. Bright MR; Curtis N; Messina NL Tuberculosis (Edinb); 2021 Dec; 131():101947. PubMed ID: 33691988 [TBL] [Abstract][Full Text] [Related]
29. Modelling the health and economic impacts ofM72/AS01 Sumner T; Clark RA; Mukandavire C; Portnoy A; Weerasuriya CK; Bakker R; Scarponi D; Hatherill M; Menzies NA; White RG Vaccine; 2024 Feb; 42(6):1311-1318. PubMed ID: 38307747 [TBL] [Abstract][Full Text] [Related]
30. A retrospective audit of neonatal BCG vaccination in Grampian, Scotland. Savul S; Duthie S Hum Vaccin Immunother; 2023 Dec; 19(3):2281737. PubMed ID: 38175950 [TBL] [Abstract][Full Text] [Related]
31. Efficacy of Bacillus Calmette-Guérin (BCG) Vaccination in Reducing the Incidence and Severity of COVID-19 in High-Risk Population (BRIC): a Phase III, Multi-centre, Quadruple-Blind Randomised Control Trial. Sinha S; Ajayababu A; Thukral H; Gupta S; Guha SK; Basu A; Gupta G; Thakur P; Lingaiah R; Das BK; Singh UB; Singh R; Narang R; Bhowmik D; Wig N; Modak DC; Bandyopadhyay B; Chakrabarty B; Kapoor A; Tewari S; Prasad N; Hashim Z; Nath A; Kumari N; Goswami R; Pandey S; Pandey RM Infect Dis Ther; 2022 Dec; 11(6):2205-2217. PubMed ID: 36242739 [TBL] [Abstract][Full Text] [Related]
33. Comparative tuberculosis (TB) prevention effectiveness in children of Bacillus Calmette-Guérin (BCG) vaccines from different sources, Kazakhstan. Favorov M; Ali M; Tursunbayeva A; Aitmagambetova I; Kilgore P; Ismailov S; Chorba T PLoS One; 2012; 7(3):e32567. PubMed ID: 22427854 [TBL] [Abstract][Full Text] [Related]
34. Fifteen year follow up of trial of BCG vaccines in south India for tuberculosis prevention. Tuberculosis Research Centre (ICMR), Chennai. Indian J Med Res; 1999 Aug; 110():56-69. PubMed ID: 10573656 [TBL] [Abstract][Full Text] [Related]
35. T-cell-based diagnosis of tuberculosis infection in children in Lithuania: a country of high incidence despite a high coverage with bacille Calmette-Guerin vaccination. Hansted E; Andriuskeviciene A; Sakalauskas R; Kevalas R; Sitkauskiene B BMC Pulm Med; 2009 Aug; 9():41. PubMed ID: 19689817 [TBL] [Abstract][Full Text] [Related]
36. Research progress on specific and non-specific immune effects of BCG and the possibility of BCG protection against COVID-19. Du J; Su Y; Wang R; Dong E; Cao Y; Zhao W; Gong W Front Immunol; 2023; 14():1118378. PubMed ID: 36798128 [TBL] [Abstract][Full Text] [Related]
37. Design of the Brazilian BCG-REVAC trial against tuberculosis: a large, simple randomized community trial to evaluate the impact on tuberculosis of BCG revaccination at school age. Barreto ML; Rodrigues LC; Cunha SS; Pereira S; Hijjar MA; Ichihara MY; de Brito SC; Dourado I Control Clin Trials; 2002 Oct; 23(5):540-53. PubMed ID: 12392870 [TBL] [Abstract][Full Text] [Related]
38. BCG vaccination: An update on current Australian practices. Taylor JW; Curtis N; Denholm J Aust J Gen Pract; 2020 Oct; 49(10):651-655. PubMed ID: 33015679 [TBL] [Abstract][Full Text] [Related]
39. A case-control study of protection against tuberculosis by BCG revaccination in Recife, Brazil. Dantas OM; Ximenes RA; de Albuquerque Mde F; da Silva NL; Montarroyos UR; de Souza WV; Pereira TC; Campelo AR; Rodrigues LC Int J Tuberc Lung Dis; 2006 May; 10(5):536-41. PubMed ID: 16704036 [TBL] [Abstract][Full Text] [Related]
40. Long-term efficacy of BCG vaccine in American Indians and Alaska Natives: A 60-year follow-up study. Aronson NE; Santosham M; Comstock GW; Howard RS; Moulton LH; Rhoades ER; Harrison LH JAMA; 2004 May; 291(17):2086-91. PubMed ID: 15126436 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]